Record #38755
IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
Journal
Publisher
Original paper date
Sep 30, 2020
Original DOI
Country
Institution
General Surgery Department, Lanzhou University Second Hospital, Lanzhou, Gansu, People’s Republic of China · Key Laboratory of Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, People’s Republic of China · Storr Liver Unit at the Westmead Millennium Institute, The University of Sydney at Westmead Hospital, Sydney, NSW 2145, Australia
Open access
No
Article type
Broad categories
Notes from Retraction Watch
see also: https://pubpeer.com/publications/F49715B1D7EB240B2005E4A56560CE
Citation lifecycle
How this paper is being cited
Pre-retraction
20
Same day
1
Post-retraction
20
% post-retraction
48.8%
~10.6 citations/yr before retraction · ~4.9 citations/yr after
— citing papers
Who is still citing this work
Loading…